ClinicalTrials.gov record
Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
ClinicalTrials.gov ID: NCT00060931
Public ClinicalTrials.gov record NCT00060931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients With Type II Diabetes Mellitus.
Study identification
- NCT ID
- NCT00060931
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 501 participants
Conditions and interventions
Conditions
Interventions
- carvedilol Drug
- metoprolol Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2001
- Primary completion
- Mar 31, 2004
- Completion
- Mar 31, 2004
- Last update posted
- Apr 13, 2015
2001 – 2004
United States locations
- U.S. sites
- 119
- U.S. states
- 24
- U.S. cities
- 100
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35211 | — |
| GSK Investigational Site | Birmingham | Alabama | 35294-0012 | — |
| GSK Investigational Site | Birmingham | Alabama | 35294-2041 | — |
| GSK Investigational Site | Columbia | Alabama | 35051 | — |
| GSK Investigational Site | Mobile | Alabama | 36608 | — |
| GSK Investigational Site | Derby | Connecticut | 06418 | — |
| GSK Investigational Site | Farmington | Connecticut | 06030 - 1410 | — |
| GSK Investigational Site | Hartford | Connecticut | 06106 | — |
| GSK Investigational Site | New Britain | Connecticut | 06050 | — |
| GSK Investigational Site | Newark | Delaware | 19713 | — |
| GSK Investigational Site | Washington D.C. | District of Columbia | 20037 | — |
| GSK Investigational Site | Washington D.C. | District of Columbia | 20422 | — |
| GSK Investigational Site | Coral Gables | Florida | 33134 | — |
| GSK Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| GSK Investigational Site | Fort Lauderdale | Florida | 33316 | — |
| GSK Investigational Site | Fort Meyers | Florida | 33907 | — |
| GSK Investigational Site | Gainesville | Florida | 32605 | — |
| GSK Investigational Site | Hollywood | Florida | 33021 | — |
| GSK Investigational Site | Hollywood | Florida | 33023 | — |
| GSK Investigational Site | Inverness | Florida | 34452 | — |
| GSK Investigational Site | Jacksonville | Florida | 32205 | — |
| GSK Investigational Site | Jacksonville | Florida | 32216 | — |
| GSK Investigational Site | Melbourne | Florida | 32901 | — |
| GSK Investigational Site | Miami | Florida | 33133 | — |
| GSK Investigational Site | Miami | Florida | 33136 | — |
| GSK Investigational Site | Miami | Florida | 33156 | — |
| GSK Investigational Site | Miami | Florida | 33176 | — |
| GSK Investigational Site | Ocala | Florida | 34471 | — |
| GSK Investigational Site | Ocala | Florida | 34474 | — |
| GSK Investigational Site | Pembroke Pines | Florida | 33024 | — |
| GSK Investigational Site | Saint Petersberg | Florida | 33705 | — |
| GSK Investigational Site | Sarasota | Florida | 34239 | — |
| GSK Investigational Site | Tamarac | Florida | 33321 | — |
| GSK Investigational Site | Tampa | Florida | 33614 | — |
| GSK Investigational Site | Augusta | Georgia | 30901 | — |
| GSK Investigational Site | Fayetteville | Georgia | 30214 | — |
| GSK Investigational Site | Lawrenceville | Georgia | 30045 | — |
| GSK Investigational Site | Savannah | Georgia | 31406 | — |
| GSK Investigational Site | Chicago | Illinois | 60616 | — |
| GSK Investigational Site | West Evanston | Illinois | 60202 | — |
| GSK Investigational Site | Newburgh | Indiana | 47630 | — |
| GSK Investigational Site | Wabash | Indiana | 46992 | — |
| GSK Investigational Site | Lexington | Kentucky | 40508 | — |
| GSK Investigational Site | New Orleans | Louisiana | 70112 | — |
| GSK Investigational Site | New Orleans | Louisiana | 70121 | — |
| GSK Investigational Site | Auburn | Maine | 04210 | — |
| GSK Investigational Site | Bangor | Maine | 04401 | — |
| GSK Investigational Site | Baltimore | Maryland | 21204 | — |
| GSK Investigational Site | Baltimore | Maryland | 21208 | — |
| GSK Investigational Site | Ayer | Massachusetts | 01432 | — |
| GSK Investigational Site | Boston | Massachusetts | 02115 | — |
| GSK Investigational Site | Haverhill | Massachusetts | 01831-2451 | — |
| GSK Investigational Site | Springfield | Massachusetts | 01107 | — |
| GSK Investigational Site | Waltham | Massachusetts | 02453 | — |
| GSK Investigational Site | Worcester | Massachusetts | 01605 | — |
| GSK Investigational Site | Worcester | Massachusetts | 01610 | — |
| GSK Investigational Site | Waterford | Michigan | 48328 | — |
| GSK Investigational Site | Gulfport | Mississippi | 39501 | — |
| GSK Investigational Site | Camden | New Jersey | 08103 | — |
| GSK Investigational Site | Hackensack | New Jersey | 07601 | — |
| GSK Investigational Site | Linwood | New Jersey | 08221 | — |
| GSK Investigational Site | Margate City | New Jersey | 08402 | — |
| GSK Investigational Site | Sea Girt | New Jersey | 08750 | — |
| GSK Investigational Site | Voorhees Township | New Jersey | 08043 | — |
| GSK Investigational Site | Buffalo | New York | 14209 | — |
| GSK Investigational Site | Flushing | New York | 11365 | — |
| GSK Investigational Site | Fulton | New York | 13069 | — |
| GSK Investigational Site | Kingston | New York | 12401 | — |
| GSK Investigational Site | Lancaster | New York | 14043 | — |
| GSK Investigational Site | Liverpool | New York | 13088 | — |
| GSK Investigational Site | New Hyde Park | New York | 11040 | — |
| GSK Investigational Site | New York | New York | 10021 | — |
| GSK Investigational Site | New York | New York | 10028 | — |
| GSK Investigational Site | New York | New York | 10032 | — |
| GSK Investigational Site | Rochester | New York | 14609 | — |
| GSK Investigational Site | Scarsdale | New York | 10583 | — |
| GSK Investigational Site | Syracuse | New York | 13202 | — |
| GSK Investigational Site | The Bronx | New York | 10461 | — |
| GSK Investigational Site | The Bronx | New York | 10467 | — |
| GSK Investigational Site | Tonawanda | New York | 14150 | — |
| GSK Investigational Site | Williamsville | New York | 14221 | — |
| GSK Investigational Site | Durham | North Carolina | 27710 | — |
| GSK Investigational Site | Hickory | North Carolina | 28601 | — |
| GSK Investigational Site | Raleigh | North Carolina | 27609 | — |
| GSK Investigational Site | Statesville | North Carolina | 28677 | — |
| GSK Investigational Site | Wilmington | North Carolina | 28412 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| GSK Investigational Site | Canton | Ohio | 44708 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45246 | — |
| GSK Investigational Site | Cleveland | Ohio | 44106 | — |
| GSK Investigational Site | Columbus | Ohio | 43212 | — |
| GSK Investigational Site | Zanesville | Ohio | 43701 | — |
| GSK Investigational Site | Camp Hill | Pennsylvania | 17011 | — |
| GSK Investigational Site | Connellsville | Pennsylvania | 15425 | — |
| GSK Investigational Site | Downington | Pennsylvania | 19335 | — |
| GSK Investigational Site | Erie | Pennsylvania | 16505 | — |
| GSK Investigational Site | Fleetwood | Pennsylvania | 19522 | — |
| GSK Investigational Site | Morrisville | Pennsylvania | 19067 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| GSK Investigational Site | Philipsburg | Pennsylvania | 16966 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15206 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15241 | — |
| GSK Investigational Site | West Grove | Pennsylvania | 19390 | — |
| GSK Investigational Site | Columbia | South Carolina | 29201 | — |
| GSK Investigational Site | Greer | South Carolina | 29651 | — |
| GSK Investigational Site | Summerville | South Carolina | 29485 | — |
| GSK Investigational Site | Bristol | Tennessee | 37620 | — |
| GSK Investigational Site | Jackson | Tennessee | 38301 | — |
| GSK Investigational Site | Memphis | Tennessee | 38163 | — |
| GSK Investigational Site | Nashville | Tennessee | 37212 | — |
| GSK Investigational Site | White River Junction | Utah | 05009 | — |
| GSK Investigational Site | Christiansburg | Virginia | 24073 | — |
| GSK Investigational Site | Falls Church | Virginia | 22044 | — |
| GSK Investigational Site | Fredericksburg | Virginia | 20401 | — |
| GSK Investigational Site | Richmond | Virginia | 23220 | — |
| GSK Investigational Site | Richmond | Virginia | 23294 | — |
| GSK Investigational Site | Salem | Virginia | 24153 | — |
| GSK Investigational Site | Springfield | Virginia | 22151 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00060931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00060931 live on ClinicalTrials.gov.